Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.25B |
| 2 |
Home Depot
HD
|
+$645M |
| 3 |
Gilead Sciences
GILD
|
+$621M |
| 4 |
Navient
NAVI
|
+$609M |
| 5 |
Exelon
EXC
|
+$583M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$1.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$611M |
| 3 |
SLM Corp
SLM
|
+$564M |
| 4 |
CIE
Cobalt International Energy, Inc
CIE
|
+$403M |
| 5 |
DuPont de Nemours
DD
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.18% |
| 2 | Financials | 7.69% |
| 3 | Technology | 7.67% |
| 4 | Healthcare | 6.64% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
5076
Centerspace
CSR
$941M
| $591K | ﹤0.01% |
6,410
-3,425
| -35% | -$304K |
|
5077
PUT
JD.com
JD
$43.6B
| $590K | ﹤0.01% |
+20,700
| New | +$539K |
|
5078
DXP Enterprises
DXPE
$2.4B
| $586K | ﹤0.01% |
7,750
-25,842
| -77% | -$2.24M |
|
5079
PUT
FTI Consulting
FCN
$4.53B
| $586K | ﹤0.01% |
15,500
-21,000
| -58% | -$693K |
|
5080
Crocs
CROX
$6.14B
| $584K | ﹤0.01% |
38,823
-58,760
| -60% | -$875K |
|
|
CATM
5081
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $583K | ﹤0.01% |
17,111
+3,762
| +28% | +$126K |
|
|
PHX
5082
DELISTED
PHX Minerals
PHX
| $581K | ﹤0.01% |
20,722
-1,740
| -8% | -$43.9K |
|
|
KSU
5083
CALL
DELISTED
Kansas City Southern
KSU
| $581K | ﹤0.01% |
5,400
+4,500
| +500% | +$465K |
|
5084
Galectin Therapeutics
GALT
$213M
| $579K | ﹤0.01% |
41,910
+36,766
| +715% | +$458K |
|
|
CNCE
5085
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $579K | ﹤0.01% |
57,345
-9,800
| -15% | -$94.6K |
|
|
JMI
5086
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $579K | ﹤0.01% |
41,077
+9,401
| +30% | +$127K |
|
5087
CALL
Vanda Pharmaceuticals
VNDA
$312M
| $578K | ﹤0.01% |
35,700
-1,000,500
| -97% | -$13.3M |
|
|
CFNL
5088
DELISTED
Cardinal Financial Corp
CFNL
| $577K | ﹤0.01% |
31,250
-5,720
| -15% | -$100K |
|
5089
PUT
Silicon Laboratories
SLAB
$7.15B
| $576K | ﹤0.01% |
11,700
+3,100
| +36% | +$147K |
|
|
OCLR
5090
DELISTED
Oclaro Inc.
OCLR
| $576K | ﹤0.01% |
262,032
+201,457
| +333% | +$504K |
|
5091
Nuveen Select Tax-Free Income Portfolio
NXP
$896M
| $575K | ﹤0.01% |
40,843
| – | – |
|
|
CMD
5092
DELISTED
PROSHARES TR II ULTRASHORT BLOOMBERG COMMODITY
CMD
| $574K | ﹤0.01% |
33,093
-58,176
| -64% | -$1.02M |
|
5093
PUT
Franco-Nevada
FNV
$42.7B
| $573K | ﹤0.01% |
+10,000
| New | +$488K |
|
5094
QuinStreet
QNST
$890M
| $573K | ﹤0.01% |
104,097
+11,457
| +12% | +$66.1K |
|
|
RP
5095
DELISTED
RealPage, Inc.
RP
| $573K | ﹤0.01% |
25,479
-21,546
| -46% | -$424K |
|
|
BNCL
5096
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $571K | ﹤0.01% |
46,279
+9,391
| +25% | +$114K |
|
5097
PUT
Coty
COTY
$2.37B
| $570K | ﹤0.01% |
33,300
+11,700
| +54% | +$190K |
|
5098
Coherent
COHR
$48.7B
| $568K | ﹤0.01% |
39,270
+14,148
| +56% | +$201K |
|
|
CYTR
5099
CALL
DELISTED
CytRx Corp
CYTR
| $567K | ﹤0.01% |
22,617
+167
| +0.7% | +$3.81K |
|
5100
Ducommun
DCO
$2.77B
| $566K | ﹤0.01% |
21,650
-12,839
| -37% | -$320K |
|
Similar funds
Goldman Sachs's Q2 2014 Portfolio in Review
As of Q2 2014, Goldman Sachs held 7,392 positions worth $319B, up 4.4% from $306B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs's Q2 2014 filing shows 646 new, 2,991 increased, 3,008 reduced and 432 closed positions. Its largest new stake was Navient: 36,826,072 shares worth $652M. The largest sale was State Street SPDR S&P Retail ETF, an estimated $1.17B.
By sector, the portfolio is most concentrated in Energy at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Technology.
- Goldman Sachs's largest Q2 2014 buy was Navient: 36,826,072 shares worth $652M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q2 2014, an estimated $1.25B increase.
- Goldman Sachs's biggest Q2 2014 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $1.17B.
- Goldman Sachs fully exited CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q2 2014, selling an estimated $59.8M.
- Goldman Sachs's ten largest holdings make up 13% of its $319B portfolio in Q2 2014.
- Goldman Sachs opened 646 new positions and closed 432 in Q2 2014.
- Goldman Sachs's portfolio value rose 4.4% quarter-over-quarter to $319B.
Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.